Latest News and Press Releases
Want to stay updated on the latest news?
-
GREENWICH, Conn., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Leverage Shares by Themes introduce six new single stock leveraged ETFs, available for trading starting January 13, 2026. These products are...
-
New Drug Application (NDA) for NonAdvSM submitted in December 2025, NDA submission for AdvSM on track for 1H 2026NDA submission for GIST on track for April 2026; bezuclastinib has the potential to be...
-
GEVORKYAN, a.s., kótovaná na pražskej burze, víta rozšírenie pôsobenia investičnej skupiny Patria Finance na Slovensko. Slovenskí investori tak získavajú ďalšiu komfortnú možnosť, ako nakupovať akcie...
-
GEVORKYAN, a.s., kótovaná na pražské burze, vítá rozšíření působení investiční skupiny Patria Finance na Slovensku. Slovenští investoři tak získávají další komfortní možnost, jak nakupovat akcie...
-
GEVORKYAN, a.s., listed on the Prague Stock Exchange, welcomes the expansion of the investment group Patria Finance into Slovakia. Slovak investors thus gain another convenient option to purchase...
-
Vera Therapeutics announces inducement grants under Nasdaq Listing Rule 5635(c)(4).
-
TORONTO, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Canadian Banc Corp. (the “Company”) is pleased to announce it has completed the overnight marketing of Preferred Shares (TSX: BK.PR.A) of the Company....
-
Athira Pharma, Inc. today announced that it has changed its name to LeonaBio, Inc.
-
Li Auto (NYSE: LI; HKEX: 2015) Q3 2025: RMB 625M net loss (≈$89.3M), revenue -36% YoY, deliveries -39% YoY—ending 11 profitable quarters.
-
WALTHAM, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering long-acting antibodies and...